Cargando…
“Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”
OBJECTIVE: The vitamin D endocrine system may have a variety of actions on cells and tissues involved in COVID-19 progression especially by decreasing the Acute Respiratory Distress Syndrome. Calcifediol can rapidly increase serum 25OHD concentration. We therefore evaluated the effect of calcifediol...
Autores principales: | Entrenas Castillo, Marta, Entrenas Costa, Luis Manuel, Vaquero Barrios, José Manuel, Alcalá Díaz, Juan Francisco, López Miranda, José, Bouillon, Roger, Quesada Gomez, José Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456194/ https://www.ncbi.nlm.nih.gov/pubmed/32871238 http://dx.doi.org/10.1016/j.jsbmb.2020.105751 |
Ejemplares similares
-
Vitamin D Endocrine System and COVID-19: Treatment with Calcifediol
por: Quesada-Gomez, Jose Manuel, et al.
Publicado: (2022) -
Calcifediol for Use in Treatment of Respiratory Disease
por: Entrenas-Castillo, Marta, et al.
Publicado: (2022) -
Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166
por: Quesada-Gomez, Jose Manuel, et al.
Publicado: (2020) -
Calcifediol Cornerstone of the Vitamin D Endocrine System
por: Quesada-Gomez, Jose Manuel, et al.
Publicado: (2023) -
Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study
por: Alcala-Diaz, Juan F., et al.
Publicado: (2021)